Acorda Therapeutics Inc EV/EBITDA
Что обозначает EV/EBITDA в Acorda Therapeutics Inc?
EV/EBITDA Acorda Therapeutics Inc является N/A
Какое определение для EV/EBITDA?
EV / EBITDA - это стоимость предприятия, деленная на прибыль до вычета процентов, налогов, обесценивания и амортизации. При помощи неё измеряется, насколько дорогой является акция, и она более действительна для сравнения компаний, чем для соотношения цены и прибыли. Она измеряет цену (в форме стоимости предприятия), которую инвестор платит в пользу денежного потока компании (в форме EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Acorda Therapeutics Inc
Что делает Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Компании с ev/ebitda похож на Acorda Therapeutics Inc
- Jia Yao имеет EV/EBITDA из N/A
- CLS USA имеет EV/EBITDA из N/A
- Overseas Chinese Town (Asia) имеет EV/EBITDA из N/A
- Starr Peak Exploration имеет EV/EBITDA из N/A
- Good Friend International имеет EV/EBITDA из N/A
- DoorDash Inc имеет EV/EBITDA из N/A
- Acorda Therapeutics Inc имеет EV/EBITDA из N/A
- Inspur International имеет EV/EBITDA из N/A
- Setubandhan Infrastructure имеет EV/EBITDA из N/A
- Avalon Works имеет EV/EBITDA из N/A
- Galileo Mining Ltd имеет EV/EBITDA из N/A
- Trine Acquisition имеет EV/EBITDA из N/A
- Dreadnought Resour имеет EV/EBITDA из N/A